Variability in the efficacy of interferon-α in Erdheim-Chester disease by patient and site of involvement: Results in eight patients

Arthritis and Rheumatism

Volumn 54, Issue 10, 2006, Pages 3330-3336

  Haroche, Julien ^a   Amoura, Zahir ^a   Trad, Salim G ^a   Wechsler, Bertrand ^a   Cluzel, Philippe ^a   Grenier, Philippe A ^a   Piette, Jean Charles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; PREDNISONE;

ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERDHEIM CHESTER DISEASE; EXOPHTHALMOS; EYELID DISEASE; FEMALE; FEVER; HISTIOCYTE; HISTIOCYTOSIS; HUMAN; HUMAN TISSUE; INTRACRANIAL HYPERTENSION; MALE; PAPILLEDEMA; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; SYSTEMIC DISEASE; TREATMENT DURATION; XANTHELASMA;

ADOLESCENT; ADULT; AGED; BIOLOGICAL RESPONSE MODIFIERS; C-REACTIVE PROTEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ERDHEIM-CHESTER DISEASE; EXOPHTHALMOS; FEMALE; HISTIOCYTES; HUMANS; INTERFERON-ALPHA; INTRACRANIAL HYPERTENSION; MALE; MIDDLE AGED; PAPILLEDEMA; PROGNOSIS; TREATMENT OUTCOME;

EID: 33750297107     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22165     Document Type: Article

References (15)

1. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, Wechsler J, Brun B, Remy M, et al. Erdheim-Chester disease: clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 1996; 75:157-69.
2. Haroche J, Amoura Z, Dion E, Wechsler B, Costedoat-Chalumeau N, Cacoub P, et al. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review. Medicine (Baltimore) 2004;83:371-92.
3. Sheidow TG, Nicolle DA, Heathcote JG. Erdheim-Chester disease: two cases of orbital involvement. Eye 2000;14 (Pt 4):606-12.
4. Boralevi F, Leaute-Labreze C, Tison F, Bioulac-Sage P, Vital C, Delbrel X, et al. Langerhans-cell histiocytosis and Erdheim-Chester disease: probably not a fortuitous association. Ann Dermatol Venereol 1998;125:335-8. In French.
5. Sistermann R, Katthagen BD. Erdheim Chester disease: a rare cause of knee and leg pain. Arch Orthop Trauma Surg 2000;120: 112-3.
6. Serratrice J, Granel B, De Roux C, Pellissier JF, Swiader L, Bartoli JM, et al. "Coated aorta": a new sign of Erdheim-Chester disease. J Rheumatol 2000;27:1550-3.
7. Bourke SC, Nicholson AG, Gibson GJ. Erdheim-Chester disease: pulmonary infiltration responding to cyclophosphamide and prednisolone. Thorax 2003;58:1004-5.
8. Smith JR, Rosenbaum JT. A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol 2001;85:1220-4.
9. Jendro MC, Zeidler H, Rosenthal H, Haller H, Schwarz A. Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil. Clin Rheumatol 2004;23:52-6.
10. Myra C, Sloper L, Tighe PJ, McIntosh RS, Stevens SE, Gregson RH, et al. Treatment of Erdheim-Chester disease with cladribine: a rational approach. Br J Ophthalmol 2004;88:844-7.
11. Mossetti G, Rendina D, Numis FG, Somma P, Postiglione L, Nunziata V. Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin- 6 soluble receptor and bisphosphonate treatment in Erdheim-Chester disease. Clin Exp Rheumatol 2003; 21:232-6.
12. Boissel N, Wechsler B, Leblond V. Treatment of refractory Erdheim-Chester disease with double autologous hematopoietic stem-cell transplantation. Ann Intern Med 2001;135:844-5.
13. Jakobson AM, Kreuger A, Hagberg H, Sundstrom C. Treatment of Langerhans cell histiocytosis with α-interferon. Lancet 1987;2: 1520-1.
14. Palomera L, M Domingo J, Soria J, Gutierrez M. Long term survival in a patient with aggressive Rosai-Dorfman disease treated with interferon α. Med Clin (Barc) 2001;116:797-8. In Spanish.
15. Braiteh F, Boxrud C, Esmaeli B, Kurzrock R. Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-α. Blood 2005;106:2992-4.